Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Koch's Disease

glucose, (beta-d)-isomer has been researched along with Koch's Disease in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	3 (27.27)	18.2507
2000's	0 (0.00)	29.6817
2010's	7 (63.64)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Masatsugu, OH; Miyake, Y; Yamasaki, S	1
Haidl, ID; Jefferies, WA; Speert, DP; Stokes, RW	1
Hall, CF; Kusner, DJ; Schlesinger, LS	1
Aldwell, FE; Cross, ML; Griffin, JF; Mackintosh, CG	1
Baldwin, SL; Cho, SN; Coler, RN; Ha, SJ; Kwon, KW; Larsen, SE; Lee, A; Reed, SG; Shin, SJ	1
Carter, D; Casper, C; Duthie, MS; Fox, CB; Reed, SG	1
Gao, S; Lu, XH; Luan, M; Sun, LL; Tian, JK; Xu, CJ; Xu, XD; Zhang, L; Zhang, QL; Zhu, W	1
Baldwin, SL; Coler, RN; Fox, CB; Lin, S; Lucas, E; Moon, JJ; Orr, MT; Phan, T; Reed, SG; Sivananthan, SJ; Vedvick, TS	1
Coler, RN; Desbien, AL; Dubois Cauwelaert, N; Hudson, TE; Orr, MT; Pine, SO; Reed, SG	1
Alarico, S; Costa, M; Empadinhas, N; Maranha, A; Nunes-Costa, D	1
EHLERT, H	1

Reviews

2 review(s) available for glucose, (beta-d)-isomer and Koch's Disease

Article	Year
Correlates of GLA family adjuvants' activities. Seminars in immunology, 2018, Volume: 39 Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Glucosides; HIV Infections; Humans; Immunity, Cellular; Immunity, Humoral; Immunogenicity, Vaccine; Leishmaniasis; Leprosy; Lipid A; Liposomes; Malaria; Mice; Schistosomiasis; T-Lymphocytes, Helper-Inducer; Toll-Like Receptor 4; Tuberculosis; Vaccines	2018
Glucosylglycerate metabolism, bioversatility and mycobacterial survival. Glycobiology, 2017, 03-04, Volume: 27, Issue:3 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Glucosides; Glycosides; Humans; Lipopolysaccharides; Mycobacterium tuberculosis; Nitrogen; Polysaccharides, Bacterial; Tuberculosis	2017

Other Studies

9 other study(ies) available for glucose, (beta-d)-isomer and Koch's Disease

Article	Year
C-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation. Journal of immunology (Baltimore, Md. : 1950), 2015, Jun-01, Volume: 194, Issue:11 Topics: Amino Acid Sequence; Animals; Bone Marrow Cells; Cell Wall; Cells, Cultured; Cord Factors; Dendritic Cells; Hydrophobic and Hydrophilic Interactions; Lectins, C-Type; Lipopolysaccharides; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Sequence Data; Mycobacterium tuberculosis; Protein Interaction Domains and Motifs; Protein Structure, Tertiary; Receptors, Immunologic; RNA, Messenger; Signal Transduction; Tuberculosis; Zymosan	2015
Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. Journal of immunology (Baltimore, Md. : 1950), 1993, Dec-15, Volume: 151, Issue:12 Topics: Animals; Antibodies, Monoclonal; Binding Sites; Female; In Vitro Techniques; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Opsonin Proteins; Phagocytosis; Phenotype; Receptors, Complement; Tetradecanoylphorbol Acetate; Tuberculosis; Zymosan	1993
Activation of phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages. The Journal of experimental medicine, 1996, Aug-01, Volume: 184, Issue:2 Topics: 2,3-Diphosphoglycerate; Adult; Benzoquinones; Diphosphoglyceric Acids; Enzyme Activation; Enzyme Inhibitors; Ethanol; Genistein; Humans; Isoflavones; Lactams, Macrocyclic; Macrophage Activation; Macrophages; Mycobacterium tuberculosis; Phagocytosis; Phosphatidic Acids; Phosphatidylethanolamines; Phospholipase D; Phosphotyrosine; Protein-Tyrosine Kinases; Quinones; Rifabutin; Signal Transduction; Tuberculosis; Zymosan	1996
Intracellular survival of virulent Mycobacterium bovis and M. bovis BCG in ferret macrophages. Veterinary microbiology, 1999, Apr-19, Volume: 66, Issue:3 Topics: Animals; Catalase; Cells, Cultured; Disease Vectors; Ferrets; Hydrogen Peroxide; Lipopolysaccharides; Macrophages, Alveolar; Mycobacterium bovis; Nitrites; omega-N-Methylarginine; Scintillation Counting; Tuberculosis; Virulence; Zymosan	1999
Long-term protective efficacy with a BCG-prime ID93/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model. Scientific reports, 2019, 10-29, Volume: 9, Issue:1 Topics: Animals; Antigens, Bacterial; BCG Vaccine; Beijing; Disease Models, Animal; Glucosides; Humans; Immunization, Secondary; Lipid A; Mice; Mycobacterium tuberculosis; Th1 Cells; Tuberculosis; Tuberculosis Vaccines; Vaccination	2019
Study on antitubercular constituents from the seeds of Nigella glandulifera. Chemical & pharmaceutical bulletin, 2013, Volume: 61, Issue:8 Topics: Antitubercular Agents; Glucosides; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nigella; Plant Extracts; Seeds; Tuberculosis	2013
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. Journal of controlled release : official journal of the Controlled Release Society, 2013, Nov-28, Volume: 172, Issue:1 Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Female; Glucosides; Humans; Immunization; Lipids; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Th1 Cells; Toll-Like Receptor 4; Tuberculosis; Tuberculosis Vaccines	2013
The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction. PloS one, 2016, Volume: 11, Issue:1 Topics: Adjuvants, Immunologic; Animals; Glucosides; Immunity, Innate; Lipid A; Mice; Th1 Cells; Tuberculosis	2016
[PAS glucoside as an infusion solution in the treatment of cavernous pulmonary tuberculosis and tuberculous meningitis]. Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung, 1954, Volume: 112, Issue:1 Topics: Aminosalicylic Acids; Glucosides; Humans; Infusions, Parenteral; Pharmaceutical Solutions; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary	1954